Related Experiment Video

Updated: May 26, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Primary cutaneous B-cell lymphomas

Werner Kempf1, Natalja Denisjuk, Katrin Kerl

  • 1Department of Dermatology, University Hospital Zurich, Switzerland. werner.kempf@access.uzh.ch

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|January 4, 2012
PubMed

Insights

Cutaneous B-cell lymphomas (CBCL) are common skin cancers. While some forms have an excellent prognosis, others require aggressive treatment, highlighting the need for accurate diagnosis.

Area of Science:

  • Dermatology
  • Oncology
  • Hematology

Background:

  • Cutaneous B-cell lymphomas (CBCL) represent the second most frequent primary cutaneous lymphomas.
  • The majority of CBCL cases include cutaneous follicle center lymphoma and cutaneous marginal zone lymphoma, typically presenting as nodules.

Purpose of the Study:

  • To differentiate between indolent and aggressive forms of CBCL.
  • To emphasize the diagnostic importance of clinico-pathologic correlation, histology, immunohistochemistry, genotyping, and staging.

Main Methods:

  • Review of clinical presentations and histopathological findings of CBCL.
  • Immunohistochemical profiling and genotyping for lymphoma subtyping.
  • Staging examinations to assess disease extent.

Main Results:

  • Cutaneous follicle center lymphoma and cutaneous marginal zone lymphoma exhibit an indolent course with a good prognosis, despite frequent recurrences.
  • Cutaneous diffuse large B-cell lymphoma, leg type, and other rare CBCL variants have a poor prognosis, necessitating multiagent chemotherapy and anti-CD20 monoclonal antibodies.

Conclusions:

  • Accurate diagnosis and classification of CBCL are critical for determining prognosis and guiding treatment strategies.
  • Distinguishing between indolent and aggressive CBCL subtypes is essential for patient management and therapeutic decisions.

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...